Embracing Digital Platforms for Combination Products

Embracing Digital Platforms for Combination Products
Although still in the early stages of their development, digital healthcare platforms have the potential to improve patient outcomes, reduce healthcare costs, and allow communication and collaboration between doctors on a global scale. Pharma IQ spoke exclusively with Helene Gustafsson, Head of Regulatory & Clinical Compliance, LEO Pharma to discuss the utilisation of digital platforms alongside drug-device combination products.


Please note: That all fields marked with an asterisk (*) are required.